EA201891730A1 - Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхности - Google Patents
Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхностиInfo
- Publication number
- EA201891730A1 EA201891730A1 EA201891730A EA201891730A EA201891730A1 EA 201891730 A1 EA201891730 A1 EA 201891730A1 EA 201891730 A EA201891730 A EA 201891730A EA 201891730 A EA201891730 A EA 201891730A EA 201891730 A1 EA201891730 A1 EA 201891730A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- ophthalmological
- treatment
- changes
- corner
- application
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 abstract 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 206010013774 Dry eye Diseases 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 210000000981 epithelium Anatomy 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 229940099563 lactobionic acid Drugs 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Офтальмологическая композиция, содержащая ассоциацию лактобионовой кислоты или ее соли и гиалуроновой кислоты или ее соли, для применения при лечении глазных расстройств, вызванных воспалительными состояниями, изменением слезной пленки, синдромом сухого глаза, окислительным стрессом, нагрузкой на глазную поверхность, старением глаза, и при ранозаживлении роговично-конъюнктивального эпителия.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2016A000543A ITUB20160543A1 (it) | 2016-02-08 | 2016-02-08 | Composizione oftalmica stabilizzante e reintegrante del film lacrimale per uso nella prevenzione delle infezioni virali |
| PCT/IB2016/056719 WO2017137820A1 (en) | 2016-02-08 | 2016-11-08 | Ophthalmic composition for the use in the treatment of eye disorders related to alterations of the corneal–conjunctival surface |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EA201891730A1 true EA201891730A1 (ru) | 2019-01-31 |
| EA035539B1 EA035539B1 (ru) | 2020-07-01 |
| EA035539B9 EA035539B9 (ru) | 2020-08-07 |
Family
ID=55969252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201891730A EA035539B9 (ru) | 2016-02-08 | 2016-11-08 | Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхности |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP3413868B1 (ru) |
| CN (1) | CN108697635B (ru) |
| EA (1) | EA035539B9 (ru) |
| ES (2) | ES2747501T3 (ru) |
| IT (1) | ITUB20160543A1 (ru) |
| PT (1) | PT3413868T (ru) |
| SM (2) | SMT201900621T1 (ru) |
| WO (2) | WO2017137820A1 (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220273772A1 (en) * | 2019-07-26 | 2022-09-01 | Pandorum Technologies Private Limited | Bioengineered formulation, process for preparing and implementations thereof |
| CN115052554A (zh) * | 2019-07-31 | 2022-09-13 | 修订光学公司 2.0 | 角膜嵌体设计和矫正视力的方法 |
| BR102020023560A8 (pt) * | 2019-11-19 | 2023-02-07 | Johnson & Johnson Consumer Inc | Composições e métodos para tratar os olhos |
| US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| CA3170370A1 (en) * | 2020-03-12 | 2021-09-16 | Martin VIDAEUS | New use and method of treatment |
| US20210299121A1 (en) * | 2020-03-31 | 2021-09-30 | Somerset Therapeutics Llc | Cetirizine ophthalmic compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006104164A (ja) * | 2004-10-08 | 2006-04-20 | Nippon Origo Kk | 新規抗菌剤組成物 |
| DE102005055275A1 (de) * | 2005-11-17 | 2007-05-24 | Ursapharm Arzneimittel Gmbh & Co. Kg | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
| CN101433519B (zh) * | 2008-12-19 | 2013-01-23 | 沈阳药科大学 | 阿奇霉素滴眼剂及其制备方法 |
| ITRM20110105A1 (it) | 2011-03-03 | 2012-09-04 | Sooft Italia Spa | Composizione ed uso di collirio antiedemigeno a base di acido lattobionico |
| CN104095869A (zh) * | 2014-07-28 | 2014-10-15 | 王卫武 | 一种治疗丘疹性荨麻疹的乳膏及其制备方法 |
-
2016
- 2016-02-08 IT ITUB2016A000543A patent/ITUB20160543A1/it unknown
- 2016-11-08 PT PT168091726T patent/PT3413868T/pt unknown
- 2016-11-08 WO PCT/IB2016/056719 patent/WO2017137820A1/en not_active Ceased
- 2016-11-08 CN CN201680081153.0A patent/CN108697635B/zh active Active
- 2016-11-08 ES ES16809172T patent/ES2747501T3/es active Active
- 2016-11-08 EA EA201891730A patent/EA035539B9/ru unknown
- 2016-11-08 EP EP16809172.6A patent/EP3413868B1/en active Active
- 2016-11-08 SM SM20190621T patent/SMT201900621T1/it unknown
-
2017
- 2017-02-02 ES ES17705172T patent/ES2758372T3/es active Active
- 2017-02-02 SM SM20190692T patent/SMT201900692T1/it unknown
- 2017-02-02 WO PCT/IB2017/050561 patent/WO2017137871A1/en not_active Ceased
- 2017-02-02 EP EP17705172.9A patent/EP3413871B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EA035539B9 (ru) | 2020-08-07 |
| EP3413871B1 (en) | 2019-11-06 |
| PT3413868T (pt) | 2019-10-10 |
| WO2017137820A1 (en) | 2017-08-17 |
| EP3413871A1 (en) | 2018-12-19 |
| WO2017137871A1 (en) | 2017-08-17 |
| CN108697635A (zh) | 2018-10-23 |
| CN108697635B (zh) | 2021-07-30 |
| EP3413868B1 (en) | 2019-08-14 |
| EA035539B1 (ru) | 2020-07-01 |
| EP3413868A1 (en) | 2018-12-19 |
| ES2758372T3 (es) | 2020-05-05 |
| ES2747501T3 (es) | 2020-03-10 |
| SMT201900692T1 (it) | 2020-01-14 |
| ITUB20160543A1 (it) | 2017-08-08 |
| SMT201900621T1 (it) | 2020-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3863658C0 (en) | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF DRY EYE | |
| EA035539B9 (ru) | Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхности | |
| HK1258588A1 (zh) | 用於治疗眼科疾病的化合物和制剂 | |
| SG11202002640YA (en) | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases | |
| JOP20170147A1 (ar) | تركيبات خاصة بالعيون | |
| BR112014005700A2 (pt) | composições oftálmicas compreendendo derivados de prostaglandina f2 alfa e ácido hialurônico | |
| CY1120642T1 (el) | Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση | |
| MX2020004730A (es) | Implantes de liberacion sostenida para reducir la presion intraocular con un efecto de duracion prolongada. | |
| MX2020012014A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
| BR112012015386B8 (pt) | composição oftálmica tópica | |
| ZA202003944B (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| RU2016136333A (ru) | Фармакологическая офтальмологическая композиция, используемая в коррекции пресбиопии, и ее введение | |
| AR107460A1 (es) | Gabapentina oftálmica para el tratamiento de las úlceras corneales | |
| EP3970692C0 (en) | LIPID-BASED OPHTHALMIC COMPOSITION FOR THE TREATMENT OF DRY EYE | |
| EP3970751C0 (en) | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF CORNEAL EDEMA | |
| AR070466A1 (es) | Composiciones de gemifloxacina oculares, procedimiento de preparacion y uso | |
| PL3808353T3 (pl) | Skład i zastosowanie roztworu oftalmicznego na bazie kwasu hialuronowego i arabinogalaktanu | |
| EP4472614C0 (en) | Ophthalmic composition comprising resveratrol for treating dry eye syndrome | |
| EA201892389A1 (ru) | Офтальмологическая композиция, содержащая синергическую комбинацию гликогена и гиалуроновой кислоты или ее соли | |
| EA202000301A1 (ru) | Композиция, лекарственное средство, многодозовый контейнер, набор | |
| EP4302767C0 (en) | OPHTHALMIC COMPOSITION COMPRISING EROCITRIN FOR THE TREATMENT OF DRY EYE SYNDROME | |
| MX2021012532A (es) | Composicion oftalmica desprovista de quelantes para su uso en un procedimiento para el tratamiento de un trastorno ocular. | |
| EP3592339C0 (en) | EYE DROPS FOR THE TREATMENT OF IRRITATION OR LESIONS DUE TO SJÖGREN'S SYNDROME | |
| HK40033459A (en) | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases | |
| EA202092742A1 (ru) | Сафинамид для лечения миотонии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TH4A | Publication of the corrected specification to eurasian patent |